CD47 and neoplasm: Blocking CD47 combined with radiotherapy has radioprotection effects in normal tissues and organs, which contribute to normal cell survival involving various tissues (muscle, skin, vascular, endothelial tissue) and bone marrow [77, 78], whereas it increases tumor cells sensitivity to radiotherapy [79].